Drugs Health Pharma

Neurocine’s mid-stage trial drug cuts schizophrenia severity symptoms

US-based Neurocrine Biosciences’ trial drug for treating schizophrenia reduced the severity of the disease symptoms in a mid-stage study of 210 adult participants.

Read More
X